[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 50.16.125.253. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 1,358
Citations 0
Research Letter
August 23/30, 2016

Trends in Use and Outcomes of Women Undergoing Hysterectomy With Electric Power Morcellation

Author Affiliations
  • 1Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, New York
  • 2Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York
JAMA. 2016;316(8):877-878. doi:10.1001/jama.2016.9432

Concern about the safety of electric power morcellation for gynecologic surgery led the US Food and Drug Administration (FDA) to issue a safety communication in April 2014 discouraging use of the devices and, in November 2014, to recommend against use of morcellation in perimenopausal and postmenopausal women.1,2 Concern has been raised that these actions may result in performance of a greater number of hysterectomies via laparotomy, with an increased risk of complications.3 We examined trends in the route of hysterectomy, use of electric power morcellators, and prevalence of abnormal pathology before and after the FDA’s guidance.

First Page Preview View Large
First page PDF preview
First page PDF preview
×